Abstract
Modeling breast cancer in the mouse has helped to better define the heterogeneity of human breast cancer. In the recent past, it has become evident that some limitations have restricted the potential benefits that can be achieved with this approach. In this review, we highlight some key points that should be taken into account when the mouse is used, with special emphasis on transgenic models.
Original language | English |
---|---|
Pages (from-to) | 2988-2991 |
Number of pages | 4 |
Journal | Journal of Cellular Physiology |
Volume | 227 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2012 |
ASJC Scopus subject areas
- Clinical Biochemistry
- Cell Biology
- Physiology